Thank you for visiting us at the RSNA

Post Thumbnail

We want to thank all the Radiologists, Technologists, Industry Companies, Manufacturers and Distributors that not only visited us at the RSNA but also provided us with beneficial information and invaluable contacts for the next step in our journey to achieve CE Mark and FDA in the next 12 to 24 months. If you would like […]

More Info »

104th Scientific Assembly and Annual Meeting

Post Thumbnail

We are excited to be launching the EMTensor BrainScanner at the RSNA 2018 104th Scientific Assembly and Annual Meeting, McCormick Place, Chicago, IL. Our team would be delighted to meet you at our booth, #4961. A full technical team will be available to discuss our technology.

More Info »

Serguei Semenov to be Key Note speaker at PRYSM Medical

Post Thumbnail

Serguei Semenov, CEO EMTensor GmbH will be the Key Note speaker at the UK’s Largest Medical Exhibition “PRYSM Medical”. The topic of the presentation will be “Novel Electromagnetic Tomographic technology and scanners for brain imaging”. For more information about the presentation please contact peter.nicholson@emtensor.com. If you would like to meet our team at the Medial […]

More Info »

Meet our team at MEDICA

Post Thumbnail

Meet our team at MEDICA, 12th – 15th November 2018 in Düsseldorf, Germany. You will find us along with our new BrainScanner G4 at Booth D57 – Hall 11.

More Info »

Professor Serguei Semenov, CEO, EMTensor GmbH was the keynote speaker the IEEE CAMA, Vasteras, Sweden

Post Thumbnail

Professor Serguei Semenov, CEO, EMTensor GmbH was the keynote speaker the IEEE CAMA, Vasteras, Sweden.  The topic of his presentation was “Electromagnetic Tomography for Human Brain Imaging.” If you would like to receive a copy of this presentation, please contact peter.nicholson@emtensor.com

More Info »

EMTensor start clinical trials of their 3rd Generation BrainScanner

EMTensor start clinical trials of their 3rd Generation BrainScanner with stroke patients at the Kepler University Klinikum (Linz), Medical Campus 111, Austria with the Department of Neurology and Psychiatry Stroke unit. These vital clinical trials are scheduled to be undertaken for the next 12 months. For more information on these trials please contact us.

More Info »